Quince Therapeutics, Inc. (QNCX)

NASDAQ

$32.51

$+4.12

(+14.02%)

Regular Market

Quince Therapeutics, Inc. (QNCX) Live Price Chart

Last updated: ⁦2026-10-09 19:26:20⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Quince Therapeutics, Inc. (QNCX) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $32.51, with a market capitalization of $27.18M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $15.10 to $909.98. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$27.18M
Open	$30.50
Day's High	$909.98
Day's Low	$15.10
Previous Close	$29.36
Volume	131.38K
Average Volume	28.95K
P/E Ratio	--
52-Week High	$909.98
52-Week Low	$15.10
Dividend Yield	--
Earnings Date	--

Quince Therapeutics, Inc. (QNCX) Stock Price Today

Quince Therapeutics, Inc. (QNCX) is currently trading at $32.51 as of 2026-10-09 19:25:00, up 10.73% ($3.15) from the previous close of $29.36

During today's regular trading session, QNCX has traded between $15.10 and $909.98, with a trading volume of 131.38K shares. The current price is near the lower end of today's range.

Quince Therapeutics, Inc. (QNCX) 7-Day Stock Price Change

Over the past seven days, Quince Therapeutics, Inc. (QNCX) moved from $31.01 to $32.51, representing a gain of 4.84% ($1.50).

The stock traded between $26.65 and $36.31 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.

The average daily volume was 27.78 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

QNCX 52-Week Price Position

Position in Range: 1.9%

52W Low$15.10

52W High$909.98

QNCX is currently trading at $32.51, placing it 1.9% of the way from its 52-week low of $15.10 to its 52-week high of $909.98. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Quince Therapeutics, Inc. (QNCX)?

Quince Therapeutics Inc is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. Its proprietary AIDE technology is an inventive drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells. Its Phase 3 asset, eDSP, leverages the AIDE technology to encapsulate DSP into a patient's own red blood cells, and is targeted to treat a rare pediatric neurodegenerative disease, A-T.

Quince Therapeutics, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	38
Exchange	NASDAQ
Company Website	https://www.quincetx.com

How to Buy Quince Therapeutics, Inc. (QNCX) Stock on MEXC

Eligible investors can buy real shares of Quince Therapeutics, Inc. (QNCX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for QNCX and Place Your Order

Open the RealStocks trading page and search for QNCX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Quince Therapeutics, Inc. (QNCX) stock price today?

Quince Therapeutics, Inc. (QNCX) is currently trading at $ 32.51, up 10.73% ($3.15) from the previous close of $ 29.36. Intraday prices update in real time during regular trading hours.

2.Is QNCX stock going up or down today?

As of 2026-10-09 19:25:00, QNCX is trading at $ 32.51, up 10.73% ($3.15) from its previous close of $ 29.36. The stock has traded between $ 15.10 and $ 909.98 during today’s regular session. Past price movements do not guarantee future results.

3.What is QNCX pre-market price?

As of 2026-10-09 19:25:00, QNCX is trading at $ 30.79 in pre-market trading, up 4.87% ($1.43) from the previous close of $ 29.36. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is QNCX after-hours price?

As of 2026-10-09 19:25:00, QNCX is trading at $ 28.50 in after-hours trading, down 2.95% ($0.86) from the regular-session close of $ 29.36. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is QNCX stock trading now?

QNCX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does QNCX sit relative to its 52-week high and low?

Over the past 52 weeks, QNCX has traded between a low of $ 15.10 and a high of $ 909.98. At $ 32.51, the stock is positioned 1.9% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Quince Therapeutics, Inc. in?

Quince Therapeutics, Inc. (QNCX) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Quince Therapeutics, Inc.'s market capitalization and where is it listed?

Quince Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 27.18M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is QNCX valued in terms of P/E ratio and EPS?

QNCX trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -93.99. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Quince Therapeutics, Inc. pay a dividend?

Quince Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.